Cassava Sciences Stock Performance
| SAVA Stock | USD 3.98 0.15 3.92% |
The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cassava Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cassava Sciences is expected to be smaller as well. At this point, Cassava Sciences has a negative expected return of -1.41%. Please make sure to confirm Cassava Sciences' value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Cassava Sciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cassava Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return 1.31 | Five Day Return (87.64) | Year To Date Return (82.72) | Ten Year Return (69.42) | All Time Return (97.47) |
Last Split Factor 1:7 | Dividend Date 2017-05-10 | Ex Dividend Date 2012-12-13 | Last Split Date 2017-05-10 |
1 | Acquisition by Kupiec James William of 100000 shares of Cassava Sciences at 26.91 subject to Rule 16b-3 | 09/06/2024 |
2 | Cassava Sciences stock gains on pact with ex-CEO | 09/18/2024 |
3 | Company News for Sep 30, 2024 | 09/30/2024 |
4 | Acquisition by Richard Barry of 600000 shares of Cassava Sciences at 27.42 subject to Rule 16b-3 | 10/01/2024 |
5 | Whats Going On With Alzheimers-Focused Cassava Sciences On Tuesday | 10/08/2024 |
6 | Cassava Sciences Lifted to Buy at HC Wainwright | 10/11/2024 |
7 | Institutions profited after Cassava Sciences, Inc.s market cap rose US72m last week but individual investors profited the most | 10/21/2024 |
8 | Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 | 10/31/2024 |
9 | Looking At Cassava Sciencess Recent Unusual Options Activity | 11/07/2024 |
10 | Insider Trading | 11/18/2024 |
11 | A Post-Mortem on Cassava Sciences | 11/26/2024 |
| Begin Period Cash Flow | 201 M |
Cassava |
Cassava Sciences Relative Risk vs. Return Landscape
If you would invest 2,871 in Cassava Sciences on August 30, 2024 and sell it today you would lose (2,473) from holding Cassava Sciences or give up 86.14% of portfolio value over 90 days. Cassava Sciences is currently does not generate positive expected returns and assumes 12.0899% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Cassava, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cassava Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cassava Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cassava Sciences, and traders can use it to determine the average amount a Cassava Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1166
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SAVA |
Estimated Market Risk
| 12.09 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cassava Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cassava Sciences by adding Cassava Sciences to a well-diversified portfolio.
Cassava Sciences Fundamentals Growth
Cassava Stock prices reflect investors' perceptions of the future prospects and financial health of Cassava Sciences, and Cassava Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cassava Stock performance.
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.46 | ||||
| Current Valuation | 85.5 M | ||||
| Shares Outstanding | 48.11 M | ||||
| Price To Book | 1.24 X | ||||
| Gross Profit | (68.03 M) | ||||
| EBITDA | (95.69 M) | ||||
| Net Income | (97.22 M) | ||||
| Cash And Equivalents | 197.23 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 14.2 M | ||||
| Current Ratio | 23.41 X | ||||
| Book Value Per Share | 3.47 X | ||||
| Cash Flow From Operations | (82.03 M) | ||||
| Earnings Per Share | (1.38) X | ||||
| Market Capitalization | 184.02 M | ||||
| Total Asset | 151.66 M | ||||
| Retained Earnings | (380.77 M) | ||||
| Working Capital | 115.44 M | ||||
About Cassava Sciences Performance
By analyzing Cassava Sciences' fundamental ratios, stakeholders can gain valuable insights into Cassava Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cassava Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cassava Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.64) | (0.61) | |
| Return On Capital Employed | (0.77) | (0.73) | |
| Return On Assets | (0.64) | (0.61) | |
| Return On Equity | (0.71) | (0.67) |
Things to note about Cassava Sciences performance evaluation
Checking the ongoing alerts about Cassava Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cassava Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cassava Sciences generated a negative expected return over the last 90 days | |
| Cassava Sciences has high historical volatility and very poor performance | |
| Net Loss for the year was (97.22 M) with loss before overhead, payroll, taxes, and interest of (68.03 M). | |
| Cassava Sciences currently holds about 197.23 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from zacks.com: A Post-Mortem on Cassava Sciences |
- Analyzing Cassava Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cassava Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Cassava Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cassava Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cassava Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cassava Sciences' stock. These opinions can provide insight into Cassava Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |